<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>RP之光爱心联盟 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-15T16:31:19+08:00</updated>
  <subtitle>rp之光爱心联盟的宗旨是：面向广大视网膜病变患者及其亲友，为他们建设一个交流信息、相互沟通的平台，增进病友间的凝聚力，共同迎接命运的挑战；提供科研、医疗信息，专家咨询等多方面的服务，提升社会对视网膜病变知识的了解与认识。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>第二届RP之光爱心联盟朗诵比赛开始了</title>
    <updated>2021-01-15T13:52:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/e5Zor8OqbXo4_OMKyvubwg</id>
    <link href="https://mp.weixin.qq.com/s/e5Zor8OqbXo4_OMKyvubwg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ProQR完成了RNA治疗 LCA10 的2/3期临床试验的注册</title>
    <updated>2021-01-15T13:52:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/iwVWL_bjWsTT7rVBC0oI5w</id>
    <link href="https://mp.weixin.qq.com/s/iwVWL_bjWsTT7rVBC0oI5w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>隔空对弈虚落子 胸怀韬略见真功——第一届RP之光爱心联盟网络象棋比赛圆满落幕</title>
    <updated>2021-01-12T10:28:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/Fj8ZjCsL6r52ZfAMx16rmQ</id>
    <link href="https://mp.weixin.qq.com/s/Fj8ZjCsL6r52ZfAMx16rmQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>RP人作品欣赏--那年花开她还在</title>
    <updated>2021-01-09T09:53:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/owkq3TlAyFUUkETywgsomQ</id>
    <link href="https://mp.weixin.qq.com/s/owkq3TlAyFUUkETywgsomQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>以色列纳米视网膜研发专家问答</title>
    <updated>2021-01-08T11:22:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/fwoNjo4oFvbacKpRNb1LIg</id>
    <link href="https://mp.weixin.qq.com/s/fwoNjo4oFvbacKpRNb1LIg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>``下一个重大步骤&#39;&#39;：T的研究人员致力于治疗视力丧失</title>
    <updated>2021-01-07T10:11:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/YxzacgM2WJA-eqcHyO8lUQ</id>
    <link href="https://mp.weixin.qq.com/s/YxzacgM2WJA-eqcHyO8lUQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>在逐渐接近最关键的读数后Biogen选择了一个新的眼科基因治疗合作伙伴</title>
    <updated>2021-01-06T11:21:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/7OuiDRsLDZep-wtLyUCqGA</id>
    <link href="https://mp.weixin.qq.com/s/7OuiDRsLDZep-wtLyUCqGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>RP天下行--相约温汤</title>
    <updated>2021-01-04T14:47:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/Mx9D_-kQ8-57Ilwn0yYRQg</id>
    <link href="https://mp.weixin.qq.com/s/Mx9D_-kQ8-57Ilwn0yYRQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Atsena Therapeutics筹集了5500万美元的A轮融资，以推进LCA1基因治疗临床计划</title>
    <updated>2020-12-18T10:48:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/Ku9DZMMmO1Qa_emq0qE1GA</id>
    <link href="https://mp.weixin.qq.com/s/Ku9DZMMmO1Qa_emq0qE1GA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>生物混合人工视网膜旨在利用活细胞恢复视力</title>
    <updated>2020-12-14T14:32:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/U4enxyZ96f6aoNzP5O40PA</id>
    <link href="https://mp.weixin.qq.com/s/U4enxyZ96f6aoNzP5O40PA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>睢瑞芳教授畅谈眼科珠峰——眼遗传病的诊治现状</title>
    <updated>2020-12-12T13:04:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-12:/s/UH2HxEu5ng5eDCUT8BPDlA</id>
    <link href="https://mp.weixin.qq.com/s/UH2HxEu5ng5eDCUT8BPDlA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>